OA07171A - Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant. - Google Patents

Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant.

Info

Publication number
OA07171A
OA07171A OA57764A OA57764A OA07171A OA 07171 A OA07171 A OA 07171A OA 57764 A OA57764 A OA 57764A OA 57764 A OA57764 A OA 57764A OA 07171 A OA07171 A OA 07171A
Authority
OA
OAPI
Prior art keywords
spirothiazolidineone
preparation
preparation process
pharmaceutical
pharmaceutical preparation
Prior art date
Application number
OA57764A
Other languages
English (en)
Inventor
Jr David L Temple
Richard E Yeager
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA07171A publication Critical patent/OA07171A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA57764A 1981-08-03 1982-08-03 Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant. OA07171A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/289,351 US4456756A (en) 1981-08-03 1981-08-03 Spirothiazolidinyl piperazine derivatives

Publications (1)

Publication Number Publication Date
OA07171A true OA07171A (fr) 1984-04-30

Family

ID=23111156

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57764A OA07171A (fr) 1981-08-03 1982-08-03 Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant.

Country Status (28)

Country Link
US (1) US4456756A (fr)
JP (1) JPS5838277A (fr)
KR (1) KR880001737B1 (fr)
AT (1) AT380477B (fr)
AU (1) AU555870B2 (fr)
BE (1) BE894021A (fr)
CA (1) CA1208642A (fr)
CH (1) CH655503B (fr)
DE (1) DE3228992A1 (fr)
DK (1) DK156219C (fr)
ES (2) ES514263A0 (fr)
FI (1) FI76794C (fr)
FR (1) FR2510571B1 (fr)
GB (1) GB2105714B (fr)
GR (1) GR76171B (fr)
HU (1) HU191505B (fr)
IE (1) IE53613B1 (fr)
IL (1) IL66433A (fr)
IT (1) IT1149026B (fr)
LU (1) LU84315A1 (fr)
NL (1) NL8203035A (fr)
NZ (1) NZ201158A (fr)
OA (1) OA07171A (fr)
PH (1) PH18688A (fr)
PT (1) PT75365B (fr)
SE (1) SE453503B (fr)
YU (1) YU44073B (fr)
ZA (1) ZA825481B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61162278A (ja) * 1985-01-09 1986-07-22 Nippon Yakin Kogyo Co Ltd 冷却手段を具えたロ−ラ−電極を含む自走式シ−ム溶接機
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
ES2052675T3 (es) * 1987-11-20 1994-07-16 Hoechst Roussel Pharma 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
JPH0270878U (fr) * 1988-11-21 1990-05-30

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT649883A (fr) * 1960-05-24
US3106552A (en) * 1960-07-19 1963-10-08 Geschickter Fund Med Res Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation
US3200118A (en) * 1961-10-31 1965-08-10 Geschickter Fund Med Res Spirocyclic hydrazine imides
US3432499A (en) * 1965-04-02 1969-03-11 Geschickter Fund Med Res Trifluoromethylazaspiranes and azaspirane diones
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
DE2862059D1 (en) * 1977-12-29 1982-11-11 Synthelabo Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
IL57569A0 (en) * 1978-06-20 1979-10-31 Synthelabo Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives

Also Published As

Publication number Publication date
ES526149A0 (es) 1985-04-16
ZA825481B (en) 1983-04-27
GB2105714A (en) 1983-03-30
GR76171B (fr) 1984-08-03
IT1149026B (it) 1986-12-03
PH18688A (en) 1985-09-05
PT75365A (en) 1982-09-01
NZ201158A (en) 1985-12-13
ATA299382A (de) 1985-10-15
DK156219B (da) 1989-07-10
JPS5838277A (ja) 1983-03-05
DK156219C (da) 1989-12-04
KR840001166A (ko) 1984-03-28
CA1208642A (fr) 1986-07-29
FI822666L (fi) 1983-02-04
ES8401763A1 (es) 1984-01-01
FI76794B (fi) 1988-08-31
AU8597382A (en) 1983-02-10
FI76794C (fi) 1988-12-12
GB2105714B (en) 1985-05-15
US4456756A (en) 1984-06-26
DE3228992A1 (de) 1983-02-17
YU44073B (en) 1990-02-28
FR2510571A1 (fr) 1983-02-04
IT8248901A0 (it) 1982-07-28
YU158582A (en) 1985-04-30
DK343782A (da) 1983-02-04
BE894021A (fr) 1983-02-03
IL66433A0 (en) 1982-12-31
IE53613B1 (en) 1988-12-21
AT380477B (de) 1986-05-26
SE8204549D0 (sv) 1982-08-02
KR880001737B1 (ko) 1988-09-10
IL66433A (en) 1985-10-31
JPH039912B2 (fr) 1991-02-12
FR2510571B1 (fr) 1987-07-10
ES514263A0 (es) 1984-01-01
LU84315A1 (fr) 1983-06-07
SE453503B (sv) 1988-02-08
HU191505B (en) 1987-02-27
PT75365B (en) 1985-11-20
FI822666A0 (fi) 1982-07-30
NL8203035A (nl) 1983-03-01
IE821851L (en) 1983-02-03
SE8204549L (sv) 1983-02-04
CH655503B (fr) 1986-04-30
AU555870B2 (en) 1986-10-16
ES8504185A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2511357B1 (fr) Cis-platine microcristallin, son procede de preparation et composition pharmaceutique le contenant
FR2514769B1 (fr) Dipropionate de beclomethasone, son procede de preparation et compositions pharmaceutiques le contenant
OA07419A (fr) Activateur de plamimogène de tissu humain, son procédé de production et composition pharmaceutique le contenant.
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
OA07172A (fr) Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant.
FR2540871B1 (fr) Amino-2 phenyl-5 benzodiazepines-1,3; procede de preparation et medicaments les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
OA06797A (fr) Composé de platine, procédé de préparation et compositions pharmaceutiques en contenant.
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FI851369L (fi) Anordning foer rening av vatten, speciellt avfallsvatten medelst ett biologiskt oxidationsfoerfarande.
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
OA07517A (fr) Procédé de préparation de rhamnose et fucose.
OA07585A (fr) Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant.
OA07171A (fr) Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant.
FR2518091B1 (fr) 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
MA19731A1 (fr) Isomere levogyre de la mequitazine , son procede de praparation et medicaments le contenant .
FR2503161B1 (fr) Nouvelles fluoroprostacyclines, leur preparation et leur application pharmaceutique
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
OA06776A (fr) Procédé de préparations pharmaceutiques.
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2551753B2 (fr) Benzotriazine-1,2,3-ones-4, procede de preparation et medicaments les contenant